Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SYNH

Syneos Health (SYNH) Stock Price, News & Analysis

Syneos Health logo

About Syneos Health Stock (NASDAQ:SYNH)

Key Stats

Today's Range
$42.97
$42.99
50-Day Range
$42.48
$42.98
52-Week Range
$22.89
$52.23
Volume
7.39 million shs
Average Volume
1.92 million shs
Market Capitalization
$4.46 billion
P/E Ratio
62.29
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

Receive SYNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.

SYNH Stock News Headlines

DeFi Coin on Verge of Breakout!
The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.
Hayward Holdings, Inc. (HAYW)
See More Headlines

SYNH Stock Analysis - Frequently Asked Questions

Syneos Health, Inc. (NASDAQ:SYNH) posted its earnings results on Wednesday, November, 3rd. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. The business's quarterly revenue was up 22.7% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Syneos Health investors own include AT&T (T), NVIDIA (NVDA), Bristol-Myers Squibb (BMY), PayPal (PYPL), Applied Materials (AMAT), Advanced Micro Devices (AMD) and Intel (INTC).

Company Calendar

Last Earnings
11/03/2021
Today
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:SYNH
Employees
28,768
Year Founded
N/A

Profitability

Net Income
$266.50 million
Pretax Margin
1.53%

Debt

Sales & Book Value

Annual Sales
$5.39 billion
Cash Flow
$6.72 per share
Book Value
$33.96 per share

Miscellaneous

Free Float
103,366,000
Market Cap
$4.46 billion
Optionable
Optionable
Beta
1.58

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:SYNH) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners